BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bai MY, Lovejoy DB, Guillemin GJ, Kozak R, Stone TW, Koola MM. Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric Disorders. Complex Psychiatry 2021;7:19-33. [PMID: 35141700 DOI: 10.1159/000515066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Sapienza J, Spangaro M, Guillemin GJ, Comai S, Bosia M. Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies. Eur Arch Psychiatry Clin Neurosci 2022. [DOI: 10.1007/s00406-022-01519-0] [Reference Citation Analysis]
2 Abd El-Fattah EE. IDO/kynurenine pathway in cancer: possible therapeutic approaches. J Transl Med 2022;20:347. [PMID: 35918736 DOI: 10.1186/s12967-022-03554-w] [Reference Citation Analysis]